Wockhardt Limited · NSE:WOCKPHARMA
Wockhardt — Q4 FY2015 Earnings Presentation
21 slides from Wockhardt's earnings presentation, May 2015
Slide 1: Wockhardt Limited Investor Presentation
Wockhardt Limited Investor Presentation By Dr. Murtaza Khorakiwala Managing Director Q4FY15 & FY14-15
Slide 2: Safe Harbor Statement
Safe Harbor Statement • Except for historical information contained herein, statements in this communication, which include words or phrases such as “will”, “aim”, “will likely result”, “would”, “believe”, “may”, “expect”, “will continue”, “anticipate”, “estimate”, “intend”, “plan”, “contemplate”, “
Slide 3: Introduction to Wockhardt
Introduction to Wockhardt Key Business Dynamics
Slide 4: Wockhardt Today
Wockhardt Today UK, Ireland, France, Switz. USA Direct Operations in India, USA Mexico India and Europe 8600 Associates employed in 21 countries Wockhardt Direct ROW operations operations Investor Presentation May 2015 4
Slide 5: Wockhardt Today
Wockhardt Today UK Ireland 9 sites Chicago in India 12 Baddi Manufacturing Locations globally Ankleshwar Daman (2 Plants) Aurangabad (5 Plants) Formulations APIs Investor Presentation May 2015 5
Slide 6: Wockhardt Today R&D Centers
Wockhardt Today 3 R&D Centers worldwide USA / UK & India Investor Presentation May 2015 6
Slide 7: Key Business Update
Key Business Update Fvocknakor \Ykks
Slide 8: Key Business Update
Key Business Update Regulatory Update UK MHRA lifted Statement of Non Compliance from L1 Facility and have also restored EU GMP certification of Kadaiya facility. MGP Facility:- 483 response was found satisfactory from US FDA. US FDA conducted inspection in L1 & Waluj facilities & observed on
Slide 9: Q4FY15 Results
Q4FY15 Results Fvocknakor \Ykks
Slide 10: Sales – Growth of 4% over Q4FY14
Sales – Growth of 4% over Q4FY14 Rs.crore Growth of 4% in Q4FY15 over Q4FY14 Investor Presentation May 2015 10
Slide 11: EBITDA – Growth of 11% over Q4FY14
EBITDA – Growth of 11% over Q4FY14 Rs.crore Growth of 11% in Q4FY15 over Q4FY14 Investor Presentation May 2015 11
Slide 12: PAT – Decline of 55% over Q4FY14
PAT – Decline of 55% over Q4FY14 Rs.crore De-growth of 55% in Q4FY15 over Q4FY14 Investor Presentation May 2015 12
Slide 13: FY 14-15 Results
FY 14-15 Results Fvocknakor \Ykks
Slide 14: Sales – Decline of 7% over FY 13-14
Sales – Decline of 7% over FY 13-14 Rs.crore Decline of 7% in FY 14-15 over FY 13-14 Investor Presentation May 2015 14
Slide 15: EBITDA – Declines by 16% over FY 13-14
EBITDA – Declines by 16% over FY 13-14 Rs.crore Declines by 16% in FY 14-15 over FY 13-14 Investor Presentation May 2015 15
Slide 16: PAT – Declines by 52% over FY 13-14
PAT – Declines by 52% over FY 13-14 Rs.crore Declines by 52% in FY 14-15 over FY 13-14 Investor Presentation May 2015 16
Slide 17: Research – 11.5% of Sales in FY14-15
Research – 11.5% of Sales in FY14-15 Investor Presentation May 2015 17
Slide 18: US Business
US Business • Declines by 21% (22% in $ terms) over Q4FY14. USA 2,500 $364 • Declines by 49% (51% in $ terms) 2,000 over FY 13-14. 1,500 • During the year 14 ANDA’s filed & Rs.cr. $179 1,000 cumulative ANDA’s pending for 500 approval is 69. 2,150 1,087 - FY 13-14 FY 14-15 Investor Presentation May 2
Slide 19: EU Operations
EU Operations UK Operations 1,500 UK £ 141 • 8 New Approvals received in FY 14-15. 1,300 1,100 • 11 New Fillings done in FY 14-15 , 1 in Q4FY15. £ 104 900 • UK operation Grows by 36% (grows by 34% £ terms) in Rs.cr. 700 500 Q4FY15. Grows by 46% (35% in £ terms) in FY 14-15. 300 964 1,405 • Among top
Slide 20: India & Emerging Markets
India & Emerging Markets • Total Emerging Markets (Including India) Grows by 26% for Q4FY15. Grows by 19% for FY 14-15. • India Business Grows by 46% for Q4FY15 and Grows by 24% during FY 14-15. • 2 new products in Q4FY15 and 42 new India & Emerging Markets (Em) 1,800 products launched in FY 14-15 i
Slide 21: For investor updates and communication please visit www.wockhardt.com
For investor updates and communication please visit www.wockhardt.com For Information please contact Arun Khatanhar Tel.: +91 22 71596228 Akhatanhar@wockhardt.com 21 Investor Presentation May 2015